3.70 +0.00 (0.00%)
ANDS
| Trade ANDS now with |
|
Stock Details
Last Trade:3.70 Change:+0.00 (0.00%) Prev Close:3.70 Open: 23.25 Days Range:3.70 – 3.70 52 Week Range: 0.60 - 3.70 Volume:9626 P/E: N/AEPS:-0.43
Recent Blog Posts
Blog Posts on 11/25/11 at 2:29pm
Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring
Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring
Blog Posts on 11/21/11 at 3:38pm
Gilead Acquiring Pharmasset - Could Achillion And Inhibitex Be Next?
Gilead Acquiring Pharmasset - Could Achillion And Inhibitex Be Next?
Blog Posts on 10/25/11 at 4:42am
Healthcare Sector's Insider Buy And Sell SEC Filings From Last Week
Healthcare Sector's Insider Buy And Sell SEC Filings From Last Week
Blog Posts on 10/23/11 at 8:32am
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Blog Posts on 10/19/11 at 12:16pm
Hepatitis C Drug Developers See Shares Rise After News Of Roche Acquisition
Hepatitis C Drug Developers See Shares Rise After News Of Roche Acquisition
Blog Posts on 10/18/11 at 9:19am
Institutional 5% Ownership Filings Last Week By The World's Leading Funds
Institutional 5% Ownership Filings Last Week By The World's Leading Funds
Blog Posts on 01/31/11 at 10:10am
3 Biotech Stocks Snapped Up by Insiders and Institutional Investors
3 Biotech Stocks Snapped Up by Insiders and Institutional Investors
Blog Posts on 10/15/10 at 12:10pm
Analyst Calls: AMSC, CBOE, ERTS, ESV, JCP, PDE, SMSI, TTWO, UAL, WFMI ...
Analyst Calls: AMSC, CBOE, ERTS, ESV, JCP, PDE, SMSI, TTWO, UAL, WFMI ...
Blog Posts on 09/12/10 at 6:52am
BMS Acquisition of ZymoGenetics Highlights Competitive Hepatitis C Treatment Race
BMS Acquisition of ZymoGenetics Highlights Competitive Hepatitis C Treatment Race
Blog Posts on 06/10/10 at 11:40am
Analyst Calls: ANDS, AZO, CHRW, CR, CRM, FDO, GIS, K, NAV, ORCL ...
Analyst Calls: ANDS, AZO, CHRW, CR, CRM, FDO, GIS, K, NAV, ORCL ...